Body
CAMBRIDGE, MA and YORK, ENGLAND - June 19, 2019 - Shimmer Research, a global leader in wearable technology for research applications, and ClearSky Medical Diagnostics, a leader in analyzing wearable data for medical applications, today announced they are partnering to bring a new level of analytic capabilities to the use of wearable sensors in clinical research.
Women's awareness of alcohol's role in boosting breast cancer risk is poor, indicates research published in the online journal BMJ Open.
Only one in five women attending breast clinics and screening appointments and only half of the staff questioned at one NHS UK centre knew that alcohol is a risk factor for breast cancer, the findings show.
Good heart and lung (cardiorespiratory) fitness in middle age is associated with a lower long term risk of chronic lung disease (COPD), suggests Danish research published online in the journal Thorax.
Physical activity that boosts fitness should be encouraged "to delay development, progression and death from COPD," conclude the researchers.
Research supported by the Accelerating Medicines Partnership (AMP) on Rheumatoid Arthritis and Systemic Lupus Erythematosus (RA/SLE) provides new insights into tissue damage for these autoimmune conditions. Findings include the identification of novel molecular signatures related to immune system signaling in kidney cells that may reflect their active role in disease process; molecular targets, including specific white blood cells, for potential treatment in lupus nephritis; and specific types of fibroblasts and white blood cells that are involved in rheumatoid arthritis.
CLEVELAND, Ohio (June 18, 2019)--Thanks to advanced medical treatments, women diagnosed with breast cancer today will likely survive the disease. However, some treatment options put these women at greater risk for a number of other health problems. A new study out of Brazil shows that postmenopausal women with breast cancer are at greater risk for developing heart disease. Results are published online in Menopause, the journal of The North American Menopause Society (NAMS).
Food neophobia, or fear of new foods, may lead to poorer dietary quality, increase the risk factors associated with chronic diseases, and thus increase the risk of developing lifestyle diseases, including cardiovascular diseases and type 2 diabetes.
These are some of the findings of a study conducted by the Finnish National Institute for Health and Welfare, the University of Helsinki, and the University of Tartu in Estonia.
When studying biological cells using optical tweezers, one main issue is the damage caused to the cell by the tool. Giovanni Volpe, University of Gothenburg, has discovered a new type of force that will greatly reduce the amount of light used by optical tweezers - and improve the study of all kinds of cells and particles.
New Haven, Conn. -- In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity. Their findings advance knowledge about leptin and weight gain, and also suggest a potential strategy for developing future weight-loss treatments, they said.
The study, led by investigators at Yale and Harvard, was published the week of June 17, 2019, in the journal PNAS.
Philadelphia, June 18, 2019 -- Autistic adolescents need the support of their parents or guardians to prioritize independence so that they are prepared for learning to drive, according to a study of specialized driving instructors who have worked specifically with young autistic drivers. These findings were compiled by researchers at Children's Hospital of Philadelphia (CHOP) and recently published in the journal Autism in Adulthood.
Adults with incident coronary heart disease (CHD) are at higher risk for faster cognitive decline in the long-term, according to a study published today in the Journal of the American College of Cardiology.
Coronary heart disease (CHD) is the leading cause of death in men and women. CHD occurs when coronary arteries become damaged due to a build-up of fat and cholesterol and can result in a heart attack or angina when the heart cannot get the blood or oxygen it needs.
Everyone knows cigarette smoking causes cancer and as a result, prices and advertising are closely regulated to discourage youth from starting. But another cancer risk, indoor tanning, which has been shown to cause melanoma, lags in regulation. Researchers at the Colorado School of Public Health have found that the tanning industry uses marketing strategies that appeal to adolescents and young adults, including unlimited tanning packages, discounts, and even offering free tanning when paired with other services like an apartment rental or gym membership.
New Rochelle, NY, June 14, 2019--A therapeutic gene delivered into the spinal canal of infant rhesus monkeys was still being expressed after nearly 4 years, with no evidence of acute or chronic neuronal toxicity, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Human Gene Therapy website through July 14, 2019.
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated, scientists at the Emory Antibiotic Resistance Center report.
At the same time, tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible, the researchers think. Combinations chosen in this way were effective in saving mice from otherwise lethal infections, but their efficacy in hospitalized patients needs to be demonstrated.
In 2012, Professor Jeroen Raes (VIB-KU Leuven Center for Microbiology) launched the Flemish Gut Flora Project. Sequencing fecal samples of over 3,000 healthy volunteers, Prof. Raes and his team defined the boundaries of a normal, health-associated gut microbiota. Next, the team turned to patient groups to identify microbiome alterations associated with diseases. Recently, they described the so-called B2 enterotype, deficient in some anti-inflammatory bacteria.
The study is part of a wider project being conducted at the Department of Optics of the University of Granada, Spain, to investigate various aids marketed as being able to "improve" colour vision among colour-blind people.
In 2018, the researchers demonstrated the ineffectiveness of the Cx-65 glasses produced by another company, EnChroma.
In their new study, they find that the O2Amp 'Oxy-Iso' glasses, marketed by the US company VINO Optics, neither improve the colour vision of people with colour-blindness nor correct their colour-blindness..